Scientists have discovered that some cancer cells pretend to be ‘super fit’ to fool normal healthy cells into giving them their nutrients, allowing them to expand and spread around the body. A team from The Institute of Cancer Research (ICR), London, found that ‘cheating’ cancer cells… Read More
Researchers at Stanford University have revealed new insights related to pancreatic cancer’s resistance to chemotherapy. In a new paper, the scientists revealed that its resistance is related to both the physical stiffness of the tissue around the cancerous cells and the chemical makeup… Read More
Korean scientists have found that HVH-2930, an innovative HSP90 inhibitor, demonstrates promising efficacy in inducing cancer cell apoptosis and overcoming treatment resistance in HER2-positive breast cancer. Unlike previous HSP90 inhibitors, the compound circumvents limitations by bypassing heat shock response (HSR) induction. Professor Jae Hong… Read More
Researchers at the Francis Crick Institute in the UK have shed light on how cancer cells survive after being cut off from oxygen, a finding that could help to prevent cancer from becoming resistant to treatment. When oxygen supplies are low, most cells change which proteins… Read More
Milan-based Newron Pharmaceuticals has reported “exceptional” one-year results from study 014/15 into evenamide as an add-on to antipsychotics for the management of treatment-resistant schizophrenia (TRS). The data demonstrated that treatment with evenamide was associated with sustained clinically significant benefit that increased throughout the one-year course of… Read More
Novartis and Medicines for Malaria Venture (MMV) will progress ganaplacide/lumefantrine-solid dispersion formulation (SDF) into Phase III development for the treatment of patients with malaria due to Plasmodium falciparum. Ganaplacide is a novel agent with a new mechanism of action, which is combined with a new formulation of… Read More
